Home/Filings/4/0001493152-22-036318
4//SEC Filing

McNeill Lori 4

Accession 0001493152-22-036318

CIK 0001106838other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 4:30 PM ET

Size

5.0 KB

Accession

0001493152-22-036318

Insider Transaction Report

Form 4
Period: 2022-12-14
McNeill Lori
Director
Transactions
  • Award

    Common Stock

    2022-12-14+3,7703,770 total
Footnotes (1)
  • [F1]On December 14, 2022, the Reporting Person was granted 3,770 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001949324

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:30 PM ET
Size
5.0 KB